Accenture CapEx decreased by 4.4% to $149.69M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 12.4%, from $170.81M to $149.69M. Over 4 years (FY 2021 to FY 2025), CapEx shows relatively stable performance with a 0.8% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $158.21M | $236.30M | $181.67M | $164.66M | $194.62M | $177.05M | $98.83M | $107.55M | $141.50M | $180.29M | $68.93M | $109.82M | $124.12M | $213.64M | $152.21M | $170.81M | $169.11M | $107.92M | $156.58M | $149.69M |
| QoQ Change | — | +49.4% | -23.1% | -9.4% | +18.2% | -9.0% | -44.2% | +8.8% | +31.6% | +27.4% | -61.8% | +59.3% | +13.0% | +72.1% | -28.8% | +12.2% | -1.0% | -36.2% | +45.1% | -4.4% |
| YoY Change | — | — | — | — | +23.0% | -25.1% | -45.6% | -34.7% | -27.3% | +1.8% | -30.3% | +2.1% | -12.3% | +18.5% | +120.8% | +55.5% | +36.2% | -49.5% | +2.9% | -12.4% |